Mercia Technologies PLC participates in PsiOxus funding round
Mercia Technologies continues to support portfolio company PsiOxus in £25m Series C funding round. Mercia Technologies PLC (AIM: MERC, “Mercia”), a Midlands based leader in the funding and commercialisation of technology businesses in the UK, has taken part in a £25 million Series C funding round in portfolio company PsiOxus Therapeutics (‘PsiOxus’ or ‘the Company’),